BMJ Open-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-10-09 ms7000001308779284 来自东京都

有人知道这个proof得多久么，proof改完之后一直没信息

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-09-27 N.Yan 来自天津

审稿速度:6.0 | 投稿命中率:50.0
经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-02-08 ms4000001489404788 来自上海

审稿速度:6.0 | 投稿命中率:75.0
偏重的研究方向：卫生政策;卫生经济学
经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！

2022年6月16日投稿；
2022年11月17日收到一审返修意见：Major Revision；
2022年12月15日一审修改稿发回；
2023年2月3日收到二审返修意见：Minor Revision；
2023年2月7日将第二次的修改稿件返回给编辑；
2023年2月8日录用

中间催稿3次，编辑很耐心，基本都是2-3天内回复。

134 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-04-21 Augustkkk 来自北京

偏重的研究方向：临床
经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2022-01-05 ms1000001829093819

投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！
2021.9.15 投稿 submitted
2021.11.6 awaiting reviewer reply
2021.11.14 awaiting reviewer selection
2021.12.20 awaiting reviewer invitation
2022.1.5 awaiting reviewer reply

96 13

展开13条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2022-10-23 ms2000000196646188

审稿速度:12.0 | 投稿命中率:50.0
偏重的研究方向：外科学
经验分享：我想问下有没有共同第一作者

75 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-07-13 lvyanxiang8302 来自陕西省

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：产科;临床研究;回顾性研究
经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice

48 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-07-24 ms1000001642921159 来自湖北省

请问接收review吗，没有看到这个文章类型

53 0

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-01-16 ms7000000162404996 来自四川省

请问提交过的朋友们，这个期刊可不可以共一阿

75 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2161693, encodeId=142b21616932a, content=有人知道这个proof得多久么，proof改完之后一直没信息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d008331328, createdName=ms7000001308779284, createdTime=Mon Oct 09 11:45:48 CST 2023, time=2023-10-09, status=1, ipAttribution=东京都), GetPortalCommentsPageByObjectIdResponse(id=2160112, encodeId=165b2160112fd, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：3月份投稿，submitted状态持续1个月，然后就是awaiting reviewer reply和 awaiting reviewer selection状态来回切换持续了4个多月，找到审稿人后只审稿不到1周，拒了，没有任何实质性意见，其中一位审稿人就一句话，部分参考文献过老。内心一万匹草泥马奔腾而过，给编辑写信表达了强烈不满，这杂志再也不会碰了。没有论坛说的送外审就会接受的说法，着急的慎投。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Wed Sep 27 22:38:27 CST 2023, time=2023-09-27, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2113697, encodeId=bba2211369e71, content=审稿速度:6.0 | 投稿命中率:75.0 偏重的研究方向：卫生政策;卫生经济学 经验分享：长长的投稿过程终于结束了，今天接到了录用通知，太开心了，感觉一切努力都没有白费，特来分享传递好运，祝大家都发文顺利！ 2022年6月16日投稿； 2022年11月17日收到一审返修意见：Major Revision； 2022年12月15日一审修改稿发回； 2023年2月3日收到二审返修意见：Minor Revision； 2023年2月7日将第二次的修改稿件返回给编辑； 2023年2月8日录用 中间催稿3次，编辑很耐心，基本都是2-3天内回复。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80c78418346, createdName=ms4000001489404788, createdTime=Wed Feb 08 23:46:09 CST 2023, time=2023-02-08, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2127406, encodeId=8efc212e4061b, content=偏重的研究方向：临床 经验分享：一审到了awaiting ME decision的状态后重新进入awaiting reviewer selection的状态，有人遇到过这种情况吗？感觉是审稿人意见不一致？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9e334751996, createdName=Augustkkk, createdTime=Fri Apr 21 08:15:55 CST 2023, time=2023-04-21, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1180905, encodeId=f1c711809055e, content=投了meta分析的protocol,分享我的投稿进度，目前已投稿三个半月，在reply和selection和invitation之间变,祈祷中！ 2021.9.15 投稿 submitted 2021.11.6 awaiting reviewer reply 2021.11.14 awaiting reviewer selection 2021.12.20 awaiting reviewer invitation 2022.1.5 awaiting reviewer reply, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b9a65642410, createdName=ms1000001829093819, createdTime=Wed Jan 05 15:51:49 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2095558, encodeId=eb1e209555813, content=审稿速度:12.0 | 投稿命中率:50.0 偏重的研究方向：外科学 经验分享：我想问下有没有共同第一作者, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d11b8217975, createdName=ms2000000196646188, createdTime=Sun Oct 23 17:20:27 CST 2022, time=2022-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2147815, encodeId=6fb1214e81598, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：产科;临床研究;回顾性研究 经验分享：回顾性研究，1月19投出去，5月4号给了大修，4个审稿人＋编辑一共给了20几条审稿意见，回复比稿件都要长，6月3号修回，7月4号又给了小修，7月7号下午修回，晚上就接收了。比较慢，但是编辑很nice, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=008a1381783, createdName=lvyanxiang8302, createdTime=Thu Jul 13 11:01:15 CST 2023, time=2023-07-13, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2149573, encodeId=e2e621495e350, content=请问接收review吗，没有看到这个文章类型, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5f245395381, createdName=ms1000001642921159, createdTime=Mon Jul 24 11:15:17 CST 2023, time=2023-07-24, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2110432, encodeId=07982110432f5, content=请问提交过的朋友们，这个期刊可不可以共一阿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ede48372031, createdName=ms7000000162404996, createdTime=Mon Jan 16 15:42:22 CST 2023, time=2023-01-16, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2143117, encodeId=b874214311e05, content=这杂志不收中药，见我写的中药两天给我拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f08599530, createdName=ms6000000123592702, createdTime=Fri Jun 16 11:32:39 CST 2023, time=2023-06-16, status=1, ipAttribution=)]

2023-06-16 ms6000000123592702

这杂志不收中药，见我写的中药两天给我拒了

61 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务